AVDL

Avadel Pharmaceuticals
AVDL

Upgrade to unlock
Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$20
6% downside
High target

5 analyst ratings

positive
5  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wells Fargo
Wells Fargo
Benjamin Burnett
20 Nov ‘25 10 days ago
UBS
UBS
Ashwani Verma
100% 1-yr AVDL win rate
28 Oct ‘25 1 month ago
Leerink Partners
Leerink Partners
Marc Goodman
23 Oct ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
100% 1-yr AVDL win rate
23 Oct ‘25 1 month ago
Jefferies
Jefferies
Andrew Tsai
22 Oct ‘25 1 month ago
Needham
Needham
Ami Fadia
40% 1-yr AVDL win rate
22 Oct ‘25 1 month ago